The independent source for health policy research, polling, and news.
661 - 680 of 112,667 Results
The once-daily oral obesity treatment could cost as little as $25 per month for those with a savings card. Medicare Part D users may also be able to get the drug for $50 beginning July 1. Meanwhile, Eli Lilly is seeing a dent in their sales due to generic GLP-1s flooding the market in India.
The generic version of Wellcovorin is still available to cerebral folate deficiency patients. More administration news is about EPA rules on coal plant ash, the surgeon general nominee, potentially deeper health care cuts, and more.
As The New York Times reported, the changes would allow HHS Secretary Robert F. Kennedy Jr. to rebuild the Advisory Committee on Immunization Practices with some or all of its previous members and resuscitate at least some of their decisions. One health expert told MedPage Today that it was "another alarming action by Secretary Kennedy."
Today's early morning highlights from the major news organizations.
Editorial writers examine these public health issues.
Each week, KFF Health News compiles a selection of health policy studies and briefs.
Plus: Two hair-growth products have been recalled because of a poisoning risk to children; how to reverse cognitive decline from social media use; and more.
The investigation pertains to a policy enacted in 2019 by the Los Angeles Unified School District that protects transgender students who might not have support at home. Other states making news: Alaska, Texas, Delaware, and more.
‘Ketamine Queen’ Jasveen Sangha is among the five people who pleaded guilty in the drug overdose death of actor Matthew Perry. She faced up to 65 years in prison. Plus, news about gabapentinoids, hormone replacement therapy, GLP-1 weight loss drugs, and more.
Health and Human Services Secretary Robert F. Kennedy Jr. says he intends to expose the "corruption" and "lies" that have harmed Americans. “We’re going to name the names of the forces that obstruct the paths to public health,” he said in a teaser video. Critics fear a podcast is just another way for him to spread misinformation.
The most recent action — higher payments to Medicare Advantage plans — will put $13 billion more in insurers' pockets, Stat reported. The policy also abandons reform that would have led to more accurate, and lower, insurance payments.
News outlets report on how the Middle East conflict is impacting medical supplies, drug prices, and even the amount of fluoride in some of Maryland's drinking water. Plus: An update on NIH payments.
Today's early morning highlights from the major news organizations.
Opinion writers delve into these public health topics.
The suspect, who is charged in the deaths of three people at a waterfront bar in Southport on Sept. 27, was evaluated by three separate mental health experts. They concluded that Nigel Max Edge was not fit to stand trial but that he “may be restored to capacity through appropriate treatment, including medication and counseling,” at which point the legal case would resume.
Hennepin County Medical Center has faced a string of financial hardships, and changes in Medicare eligibility under the One Big Beautiful Bill Act could cause even more stress. A proposed tax increase, if passed by the Legislature, might stave off a June closure of the safety-net hospital.
The Advisory Committee on Immunization Practices' amended charter — which calls for a “balance of specialty areas" — was published Monday in the Federal Register and likely will be filed next week after a required seven-day notice is fulfilled. This comes after the previous committee was blocked by a federal judge.
A study in JAMA found that many patients are not receiving genetic sequencing, which can often greatly improve a person's chances of survival. Patients with a low income, Medicare or Medicaid coverage, and those of Black or Hispanic ethnicity were less likely to receive sequencing. Also, advocates worry New York may be rolling back Medicaid coverage of biomarker precision testing.
There's also been a 15% reduction in prior authorizations for Medicare Advantage since June, when about 50 plans signed on to the reform pledge, Fierce Healthcare reported. In other industry news: Jefferson Health sues Aetna; most Americans still prefer getting medical advice from providers over AI; and more.
The state of Louisiana has argued that allowing the sale of mifepristone at the federal level prevents it from enforcing its strict ban on abortion. Federal Judge David Joseph, a Trump appointee, said that he would follow an FDA study of the drug that is in the works and asked the FDA for an update of its investigation within six months, AP reported.
© 2026 KFF